* During the ATHENA trial, the FDA-approved cobas® HPV 4800 Test was run on the cobas® 4800 System. In April 2020, cobas® HPV for use on the cobas® 6800/8800 System received FDA approval as well, for 3 different indications; HPV primary screening for women 25+, co-testing with Pap cytology and ASC-US triage.
COBAS and CINTEC are trademarks of Roche. All other trademarks are property of their respective owners.
